MapLight Therapeutics
Business Services · Massachusetts, United States · 49 Employees
View Company Info for Free
About
Headquarters
1500 District Ave, Burlington, Massachusetts, 0...Phone Number
(617) 984-6300Website
www.maplightrx.comRevenue
$10.4 MillionIndustry
Most Recent Scoops
Hiring Plans
MapLight Therapeutics has more open roles in Medical & Health than it has had at any time in the past 12 months.
Open Position
Highlights
$225M
Total Funding Amount
$225M
Most Recent Funding Amount
1
Number of Funding Rounds
Who is MapLight Therapeutics
MapLight is a therapeutics company developing a unique discovery platform that combines cutting edge technologies to uncover the individual circuits that misfire in brain disorders and target those circuits with effective, safe therapeutics that improve patient lives.Explore more
MapLight Therapeutics Org Chart
Is MapLight Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
MapLight Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on MapLight Therapeutics recently announced quarterly report
Click to see if MapLight Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when MapLight Therapeutics launches new products
Funding: Get notified immidiatlly once MapLight Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at MapLight Therapeutics
Check if MapLight Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if MapLight Therapeutics is spiking on competitors!
Recommended Actions
Find VP level buyers at MapLight Therapeutics
Find 3 more new buyers
Compare Similar Companies to MapLight Therapeutics
Compare insights from companies similar to MapLight Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
MapLight Therapeutics
$10.4M
49
MapLight Therapeutics financials insights
Gather financial insights about MapLight Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
MapLight Therapeutics Employee Growth Rate
View MapLight Therapeutics’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
MapLight Therapeutics Tech Stack
A closer look at the technologies used by MapLight Therapeutics
Most Recent Scoops
Hiring Plans
MapLight Therapeutics has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Open Position
Open Position
Open Position
MapLight Therapeutics News & Media
MAPLIGHT THERAPEUTICS APPOINTS MARIA WALKER TO BOARD OF DIRECTORS
Walker brings 30+ years of investment, operational, and advisory experience SAN FRANCISCO and BOSTON, April 3, 2024 /PRNewswire/ -- MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted novel therapeutics to improve the lives of patients suffering...MAPLIGHT THERAPEUTICS ANNOUNCES INITIATION OF PHASE 1 CLINICAL TRIAL FOR ML-007/PAC, UNDER DEVELOPMENT FOR SCHIZOPHRENIA AND ALZHEIMER'S DISEASE PSYCHOSIS
Study to evaluate safety and tolerability of extended-release fixed dose combination ML-007/PAC with precision-matched release kinetics in advance of planned Phase 2 clinical trials ML-007/PAC dosing regimens to be assessed in healthy non-elderly and elderly adults SAN FRANCISCO and...MAPLIGHT THERAPEUTICS EXPANDS EXECUTIVE LEADERSHIP TEAM WITH APPOINTMENT OF VISHWAS SETIA AS CHIEF FINANCIAL OFFICER
Mr. Setia brings significant advisory and execution experience across capital markets and strategic transactions Jon Gillis will transition to Chief Administrative and Accounting Officer Changes to the executive leadership team support MapLight's next stage of growth and development SAN...MAPLIGHT THERAPEUTICS ANNOUNCES COMPLETION OF PHASE 1 CLINICAL TRIAL FOR NOVEL M1/M4 MUSCARINIC AGONIST IN DEVELOPMENT FOR SCHIZOPHRENIA AND ALZHEIMER'S DISEASE PSYCHOSIS
Extended-release ML-007 was evaluated for safety, tolerability, and pharmacokinetic profile in healthy volunteers across several dosing regimens, alone and when co-administered with an extended-release muscarinic antagonist Extended-release ML-007 was well tolerated at all doses including...
Read more news
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding MapLight Therapeutics
Sign Up for FreeTo access detailed company insights
MapLight is a therapeutics company developing a unique discovery platform that combines cutting edge technologies to uncover the individual circuits that misfire in brain disorders and target those circuits with effective, safe therapeutics that improve patient lives.... Read More
